Clinical Trials Insight: 700029950

Trial Profile

Clinical Trials Insight: 700029950

Discontinued
Phase of Trial: Phase III

Latest Information Update: 23 Apr 2008

At a glance

  • Drugs Renzapride (Primary)
  • Indications Irritable bowel syndrome
  • Focus Registrational; Therapeutic Use
  • Sponsors Alizyme
  • Most Recent Events

    • 06 Mar 2008 Recruitment is expected to commence following conclusion of a commercial deal, according to a Alizyme media release.
    • 18 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top